Ditapis dengan
Combating the Prescription Painkiller Epidemic: A National Prescription Drug …
Prescription painkiller abuse is the fastest growing drug problem in the United States. In the past year, approximately one out of twenty Americans reported misuse or abuse of prescription painkillers. Several factors contribute to the prescription painkiller epidemic. Drug abusers use various methods—such as doctor shopping, paying with cash, and filling prescriptions in different states—t…
- Edisi
- 40 (2014):
- ISBN/ISSN
- -
- Deskripsi Fisik
- American Journal of Law & Medicine, 40 (2014): 85-112
- Judul Seri
- Journal of Law & Medicine
- No. Panggil
- -
Public Assistance, Drug Testing, and the Law: The Limits of Population-Based …
In Populations, Public Health and the Law, legal scholar Wendy Parmet urges courts to embrace population-based legal analysis, a public health inspired approach to legal reasoning. Parmet contends that population-based legal analysis offers a way to analyze legal issues—not unlike law and economics—as well as a set of values from which to critique contemporary legal discourse. Population-ba…
- Edisi
- 40 (2014)
- ISBN/ISSN
- -
- Deskripsi Fisik
- American Journal of Law & Medicine, 40 (2014): 26-84
- Judul Seri
- Journal of Law & Medicine,
- No. Panggil
- -
Jimmo and the Improvement Standard: Implementing Medicare Coverage Through Re…
In Jimmo v. Sebelius, the plaintiffs alleged that the Centers for Medicare and Medicaid Services (CMS) regularly and improperly denied Medicare reimbursement for outpatient therapy treatment when the beneficiary did not show a likelihood of improvement. These denials, based on policy manuals and other guidance, appear to contradict the government’s own regulations, which specifically prohibit…
- Edisi
- 40 (2014)
- ISBN/ISSN
- -
- Deskripsi Fisik
- American Journal of Law & Medicine, 40 (2014): 7-25
- Judul Seri
- Journal of Law & Medicine
- No. Panggil
- -
Bias at the Gate?: The Pharmaceutical Industry’s Influence on the Federally…
INTRODUCTION As of 2002, the Federal Food and Drug Administration (FDA) had approved Neurontin, a drug developed by the pharm.aceutical company Pfizer, for two uses, the treatment of epilepsy and pain related to shingles. 1. A staggering ninety-four percent of Neurontin prescriptions in the prior five years, however, were for other (non-FDA) approved uses. 2.These other uses effectively trip…
- Edisi
- VOL. 40 NO. 1 2014
- ISBN/ISSN
- -
- Deskripsi Fisik
- American Journal of Law & Medicine, 40 (2014): 141-163
- Judul Seri
- Journal of Law & Medicine
- No. Panggil
- -
Obamacare’s Impact on Labor Markets: Limits on the Predictive Value of Romn…
There has been great debate about the potential labor market impact of the Affordable Care Act (“ACA” or “Obamacare”). Some have pointed to Massachusetts as the harbinger of what is to come nationally,1 while others have predicted massive dumping of employer-based insurance.2 An extension of this labor market debate was on full display during the summer of 2012.3 Critics seized on a McK…
- Edisi
- (2014) 40
- ISBN/ISSN
- -
- Deskripsi Fisik
- American Journal of Law & Medicine, 40 (2014): 215-230
- Judul Seri
- Law & Medicine
- No. Panggil
- -
Preemption and the MLR Provision of the Affordable Care Act
This Note focuses on the medical loss ratio provision (“MLR Provision”) of the Patient Protection and Affordable Care Act (ACA).1 The MLR Provision states that health insurance companies must spend at least a certain percentage of their premium revenue on “activities that improve healthcare quality” (in other words, meet a minimum threshold medical loss ratio) and comply with reporting …
- Edisi
- (2014) 40
- ISBN/ISSN
- -
- Deskripsi Fisik
- American Journal of Law & Medicine, 40 (2014): 280-297
- Judul Seri
- Law & Medicine
- No. Panggil
- -
Health Insurance Is Dead; Long Live Health Insurance
Today, health insurance is no longer simply a class of insurance that covers risks to health, and it has not been so for many years.argues that health insurance has become a unique form of insurance—a mechanism to pay for healthcare that uses risk spreading as one of several pricing methods.explains how the ACA builds on this important payment function to create a complex social insurance sys…
- Edisi
- (2014) 40
- ISBN/ISSN
- -
- Deskripsi Fisik
- American Journal of Law & Medicine, 40 (2014): 195-214
- Judul Seri
- Law & Medicine
- No. Panggil
- -
Beyond Payment and Delivery Reform: The Individual Mandate’s Cost-Control P…
In a symposium1 focused on healthcare cost control, most of our authors have unsur prisingly highlighted and assessed Obamacare’s payment and delivery reforms—the supply-side efforts to decrease costs of medical treatment.2 But there is another party in healthcare decision-making who is equally or even more important: the patient. The question we will tackle here is whether the individual m…
- Edisi
- (2014), 40
- ISBN/ISSN
- -
- Deskripsi Fisik
- American Journal of Law & Medicine 40 (2014): 185-194
- Judul Seri
- Law & Medicine
- No. Panggil
- -
Cells as Drugs?: Regulating the Future of Medicine
Regenerative Sciences, LLC, a Colorado company run by physicians, created the Regenexx-C (Cultured) (“Regenexx-C”) procedure to treat bone pain. The procedure involves harvesting a patient’s own mesenchymal stem cells (MSCs), expanding the cells ex vivo, and then injecting the resulting cellular product into the site of injury, usually an injured joint. 2 The MSCs then repair the damaged …
- Edisi
- (2014) 40
- ISBN/ISSN
- -
- Deskripsi Fisik
- American Journal of Law & Medicine, 40 (2014): 298-321
- Judul Seri
- Law & Medicine,
- No. Panggil
- -
Karya Umum 
Filsafat 
Agama 
Ilmu-ilmu Sosial 
Bahasa 
Ilmu-ilmu Murni 
Ilmu-ilmu Terapan 
Kesenian, Hiburan, dan Olahraga 
Kesusastraan 
Geografi dan Sejarah